| |
| | FSMA: Valproic Acid Shows Promise for Treating SMA (Site not responding. Last check: 2007-11-07) |
 | | Valproic acid, on the other hand, is usually well-tolerated and has been used for decades to treat people with epilepsy. |
 | | Treatment with valproic acid can lead to liver toxicity, especially in children under 2 years of age, and safe doses of the drug may not be able to increase the amount of SMN protein enough to reduce symptoms of the disease, she adds. |
 | | Researchers led by Kathryn Swoboda, M.D., at the University of Utah, are now conducting a preliminary clinical trial of valproic acid in children with SMA who are 2 years of age and older in order to determine whether the drug is safe enough for further study in children with this disorder. |
| www.fsma.org /vpa2004.shtml (1050 words) |
|